Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.
Open | $1.97 |
Close | $2.01 |
Volume / Avg. | 1.40M / 1.13M |
Day Range | 1.75 - 2.08 |
52 Wk Range | 1.25 - 32.42 |
Market Cap | $59.66M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 7.47% |
Days to Cover | 1.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.
Other companies in Aerovate Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), HOOKIPA Pharma (NASDAQ:HOOK), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA) and Intensity Therapeutics (NASDAQ:INTS).
There is no analysis for Aerovate Therapeutics.
Aerovate Therapeutics has a consensus price target of $11.75.
The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.07 last updated July 26, 2024 at 7:42 PM EDT.
There are no upcoming dividends for Aerovate Therapeutics.
Aerovate Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Aerovate Therapeutics.
Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.